Effect of Body Suspension and Tilting Exercises in Parkinson's Disease
1 other identifier
interventional
40
1 country
1
Brief Summary
This study evaluates the effect of body suspension and tilting exercises (performed in Chordata apparatus) on the balance and mobility of subjects with Parkinson disease. Half of patients will perform the exercise protocol while the other half will receive passive muscle stretching and maintain the usual routine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Sep 2015
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedFirst Posted
Study publicly available on registry
May 5, 2016
CompletedNovember 28, 2016
November 1, 2016
8 months
April 28, 2016
November 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Timed Up and Go Test
Measurement of the time in seconds for a person to rise from sitting from a standard arm chair, walk 3 meters, turn, walk back to the chair, and sit down. The person wears regular footwear and customary walking aid.
At 8th week (in the end of exercise protocol).
Secondary Outcomes (6)
Berg Balance Test
At baseline, at 8th week (in the end of exercise protocol) and at 16th week (follow-up).
Functional Reach Test
At baseline, at 8th week (in the end of exercise protocol) and at 16th week (follow-up).
Baropodometry (Stabilometric parameters)
At baseline, at 8th week (in the end of exercise protocol) and at 16th week (follow-up).
Unified Parkinson Disease Rating Scale (UPDRS)
At baseline, at 8th week (in the end of exercise protocol) and at 16th week (follow-up).
Parkinson's Disease Questionnaire (PDQ-39)
At baseline, at 8th week (in the end of exercise protocol) and at 16th week (follow-up).
- +1 more secondary outcomes
Other Outcomes (1)
Hoehn and Yahr Staging of Parkinson's Disease
This test will be performed just at baseline (to classify the subjects).
Study Arms (2)
Intervention group
EXPERIMENTALSubjects submitted to a 30-minute session of suspension and tilting exercises on the Chordata equipment (PI: 0804871-1 and BR 10 2012 009901-2) twice a week for eight weeks.
Control group
SHAM COMPARATORSubjects submitted to a 30-minute passive muscle stretching session twice a week for eight weeks.
Interventions
The body suspension and tilting exercise program (Chordata Method) involved suspending the body in the apparatus while performing tilting exercises. The Chordata apparatus consists of a steel structure with special springs and a harness specifically manufactured for practicing the Chordata Method. During the training sessions, the prescribed exercises emphasize the repetition of movements designed to promote different types of muscle contractions (concentric, eccentric, static) performed in different body positions and joint angles. Thus, when using the method, patients experience maximal functional performance beyond to the body mass centre, activating trunk antagonist muscles and motor memory evocation. Each session lasts 30 minutes.
Subjects receiving submitted a global muscle stretching session twice a week for eight weeks. During this period. All participants are requested to don't engage in any additional type of exercise program or physical activity throughout the study period.
Eligibility Criteria
You may qualify if:
- Subjects able to go to training or assessment places;
- Subjects that are agreement with the study protocol and sign the ;
- Subjects in stage I, II or III of Parkinson disease according to the Hoehn and Yahr scale.
You may not qualify if:
- Subjects do not keep their usual routine (apart of the research protocol);
- Subjects with physical or functional limitations that prevent the assessment test battery;
- Subjects with heart or lung diseases that prevent the exercise performance;
- Subjects with cancer;
- Subjects with major visual deficits;
- Subjects with recurrent vertigo;
- Subjects with uncontrolled systemic blood pressure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Serviço de Neurologia do Hospital São Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Irênio G da Silva Filho, PhD
Pontifícia Universidade Católica do Rio Grande do Sul
- STUDY CHAIR
Carlos Roberto M Rieder, PhD
Hospital de Clínicas de Porto Alegre
- STUDY DIRECTOR
Régis G Mestriner, PhD
Pontifícia Universidade Católica do Rio Grande do Sul
- PRINCIPAL INVESTIGATOR
Charlene B de Oliveira, MSc
Pontifícia Universidade Católica do Rio Grande do Sul
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2016
First Posted
May 5, 2016
Study Start
September 1, 2015
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
November 28, 2016
Record last verified: 2016-11